Literature DB >> 22543914

An overview of current diagnosis and treatment in ovarian cancer.

Tim Mould1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22543914     DOI： 10.1097/IGC.0b013e318251c8e3

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN： 1048-891X            Impact factor:   3.437


× No keyword cloud information.
  7 in total

1.  Mediastinal involvement in ovarian cancer.

Authors:  Nwabundo Nwankwo; Alan D Gilman; Aibek E Mirrakhimov; Nkemakolam A Iroegbu
Journal:  BMJ Case Rep       Date:  2013-05-04

2.  Combination cytotoxicity of backbone degradable HPMA copolymer gemcitabine and platinum conjugates toward human ovarian carcinoma cells.

Authors:  Acharaporn Duangjai; Kui Luo; Yan Zhou; Jiyuan Yang; Jindřich Kopeček
Journal:  Eur J Pharm Biopharm       Date:  2013-12-04       Impact factor: 5.571

3.  Biodegradable multiblock poly(N-2-hydroxypropyl)methacrylamide gemcitabine and paclitaxel conjugates for ovarian cancer cell combination treatment.

Authors:  Nate Larson; Jiyuan Yang; Abhijit Ray; Darwin L Cheney; Hamidreza Ghandehari; Jindřich Kopeček
Journal:  Int J Pharm       Date:  2013-07-01       Impact factor: 5.875

4.  Cardamonin enhances the anti-proliferative effect of cisplatin on ovarian cancer.

Authors:  Peiguang Niu; Daohua Shi; Shusheng Zhang; Yanting Zhu; Jintuo Zhou
Journal:  Oncol Lett       Date:  2018-01-08       Impact factor: 2.967

5.  A phase I trial of KX2-391, a novel non-ATP competitive substrate-pocket- directed SRC inhibitor, in patients with advanced malignancies.

Authors:  Aung Naing; Roger Cohen; Grace K Dy; David S Hong; Lyn Dyster; David G Hangauer; Rudolf Kwan; Gerald Fetterly; Razelle Kurzrock; Alex A Adjei
Journal:  Invest New Drugs       Date:  2013-01-30       Impact factor: 3.850

6.  The apoptotic mechanisms of MT-6, a mitotic arrest inducer, in human ovarian cancer cells.

Authors:  Mei-Chuan Chen; Yi-Chiu Kuo; Chia-Ming Hsu; Yi-Lin Chen; Chien-Chang Shen; Che-Ming Teng; Shiow-Lin Pan
Journal:  Sci Rep       Date:  2017-04-07       Impact factor: 4.379

7.  Left inguinal adenopathy two years after cytoreductive surgery: a rare sign of recurrence.

Authors:  Aibek E Mirrakhimov; Nwabundo Nwankwo; Aram Barbaryan; Raya Saba; Alaa M Ali; Shawn G Kwatra; Nasir Hussain; Mourad H Senussi; Erwin Velasquez Kho; Alan D Gilman
Journal:  Case Rep Oncol       Date:  2013-01-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.